These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13634554)

  • 21. [Coinfection in hepatitis].
    Häussinger D; Erhardt A; Oette M
    Z Gastroenterol; 2004 Aug; 42(8):724-30. PubMed ID: 15314724
    [No Abstract]   [Full Text] [Related]  

  • 22. TREATMENT of liver disease.
    Gastroenterology; 1953 Oct; 25(2):300-1. PubMed ID: 13107926
    [No Abstract]   [Full Text] [Related]  

  • 23. [Data on ACTH therapy of hepatitis].
    MULLER I
    Orv Hetil; 1955 Jan; 96(2):34-6. PubMed ID: 14384251
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dietary regimen in acute hepatitis].
    MEEROFF M
    Prensa Med Argent; 1953 Aug; 40(35):2330-6. PubMed ID: 13112022
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of continual follow-up studies in hepatitis].
    KLIMA R; RIEDER H
    Wien Med Wochenschr; 1959 May; 109(19-20):416-9. PubMed ID: 13660048
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of acute hepatitis].
    BECKMANN K
    Dtsch Z Verdau Stoffwechselkr; 1953; 9():244-52. PubMed ID: 13150961
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epinephrine injections as cortisone substitute with special reference to hepatitis].
    FERENCZI A
    Z Gesamte Inn Med; 1958 Aug; 13(16):601-5. PubMed ID: 13593549
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatitis therapy with fructose in diabetes mellitus].
    SCHNEIDERBAUR A; LHOTKA E
    Wien Med Wochenschr; 1960 Oct; 110():808-11. PubMed ID: 13748275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statistics on the delta-hydrocortisone therapy of acute icterogenic hepatitis].
    MAINGUET P; CAROLI J
    Sem Hop; 1959 Jun; 35(27):1974-86. PubMed ID: 13668626
    [No Abstract]   [Full Text] [Related]  

  • 30. [Good effect of spleen extract on acute hepatitis in splenectomized patients].
    CULIK J
    Cas Lek Cesk; 1955 May; 94(21):575-6. PubMed ID: 14390523
    [No Abstract]   [Full Text] [Related]  

  • 31. [The therapy of chronic hepatitis and liver cirrhoses with liver-mitochondrial suspensions].
    HOETZL HA
    Munch Med Wochenschr; 1960 Sep; 102():1670-4. PubMed ID: 13714958
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of the treatment of certain liver diseases with the potassium salt of orotic acid].
    DEMEULENAERE L
    Brux Med; 1961 Jul; 41():1045-54. PubMed ID: 13721751
    [No Abstract]   [Full Text] [Related]  

  • 33. [Great success achieved in hepatitis contral and prevention].
    Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):1. PubMed ID: 19799001
    [No Abstract]   [Full Text] [Related]  

  • 34. [Case-controlled study of entecavir treatment for chronic severe hepatitis B].
    Xiao GM; He KY; Jia WD; Lei CL; Yang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):56-8. PubMed ID: 19799020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of hepatitis C in a patient with advanced AIDS and decompensated cirrhosis.
    Johanson FD; Balliram DB
    AIDS Read; 2003 Oct; 13(10):494-6, 500-1. PubMed ID: 14596227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.
    Planas R; Ballesté B; Alvarez MA; Rivera M; Montoliu S; Galeras JA; Santos J; Coll S; Morillas RM; Solà R
    J Hepatol; 2004 May; 40(5):823-30. PubMed ID: 15094231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study.
    Xu JH; Yu YY; Si CW; Zeng Z; Wang QH; Luo DD; Zhou YX; Zeng MD; Qiao GY; Yao JL; Lu WL
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):381-5. PubMed ID: 15313673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examination of the value of treatment of decompensated viral hepatitis patients by intentionally coinfecting them with an apathogenic IBDV and using the lessons learnt to seriously consider treating patients infected with HIV using the apathogenic hepatitis G virus.
    Bakács T; Mehrishi JN
    Vaccine; 2004 Nov; 23(1):3-13. PubMed ID: 15519701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.